Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Wave Life Sciences Ltd. (NASDAQ: WVE) closed at $8.30 in the last session, up 1.22% from day before closing price of $8.20. In other words, the price has increased by $1.22 from its previous closing price. On the day, 1.04 million shares were traded. WVE stock price reached its highest trading level at $8.35 during the session, while it also had its lowest trading level at $8.02.
Ratios:
We take a closer look at WVE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.99 and its Current Ratio is at 0.99. In the meantime, Its Debt-to-Equity ratio is 6.56 whereas as Long-Term Debt/Eq ratio is at 4.93.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $11.
On September 09, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $10.JP Morgan initiated its Overweight rating on September 09, 2024, with a $10 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 27 ’24 when GSK plc bought 2,791,930 shares for $8.00 per share. The transaction valued at 22,335,440 led to the insider holds 16,775,691 shares of the business.
Moran Kyle sold 17,146 shares of WVE for $154,314 on Sep 25 ’24. The Chief Financial Officer now owns 19,777 shares after completing the transaction at $9.00 per share. On Sep 25 ’24, another insider, KYLE MORAN, who serves as the Officer of the company, bought 17,146 shares for $9.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WVE now has a Market Capitalization of 1262355456 and an Enterprise Value of 918115264. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.62. Its current Enterprise Value per Revenue stands at 8.309 whereas that against EBITDA is -11.567.
Stock Price History:
Over the past 52 weeks, WVE has reached a high of $9.92, while it has fallen to a 52-week low of $3.50. The 50-Day Moving Average of the stock is 36.56%, while the 200-Day Moving Average is calculated to be 50.17%.
Shares Statistics:
According to the various share statistics, WVE traded on average about 1.18M shares per day over the past 3-months and 4203250 shares per day over the past 10 days. A total of 119.16M shares are outstanding, with a floating share count of 101.38M. Insiders hold about 20.83% of the company’s shares, while institutions hold 73.39% stake in the company. Shares short for WVE as of 1726185600 were 3532232 with a Short Ratio of 3.00, compared to 1723680000 on 3349379. Therefore, it implies a Short% of Shares Outstanding of 3532232 and a Short% of Float of 5.81.
